Explicit inclusion of European Reference Networks (ERNs) in the ECF is vital for health competitiveness and rare disease care The current proposal for the European Competitiveness Fund (ECF), specifically Chapter V (Articles 36 and 37) on Health, biotech, agriculture and bioeconomy, aligns perfectly with the mission of European Reference Networks (ERNs).
Radboudumc
Academic / research · Netherlands
not in the EU Transparency RegisterThis organization files on consultations without a register number, so its record here is built from its filings alone. Register facts (staff, costs, accreditations) are not available for it.
Counts here are a floor, never a total: they cover the 655 consultation files tracked so far (56,999 submissions, mostly 2021–26), so an organization's real filing history is larger, not smaller.
Track Radboudumc in PolicySpeak: request access →
Work at Radboudumc? so we know who speaks for it.
Their record over time
Radboudumc filed 2 positions between 20 Oct 2025 and 23 Oct 2025, across 1 of the 655 legislative files tracked here, attaching a full position paper 1 time.
What they argued
I would like to highlight the critical role of the European Reference Networks (ERNs) in addressing rare diseases across Europe. These networks form a cornerstone of European solidarity in healthcare by ensuring that patients with rare conditionsregardless of their geographical locationcan access the best available knowledge and expertise.
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Put Radboudumc next to another organization. Same files, same register facts, side by side. Compare →
Is this your organization?
Everything on this page comes from Radboudumc’s own submissions to the European Commission. We have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.